Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The letters from the attorney to CM probably mentioned areas of prior art

we currently get 50percent after expenses. but we also own 50 percent now that moore allegedly is partners with acer do not know those parameters, we should step up to 75 percent currently tpl divides with moore that should now be challenged, and since the mmp contract have had to be violated by moore. cj talk to us what do we get for all of this?

Share
New Message
Please login to post a reply